¡Ya estamos en ! Descubre más
QTNT

Quotient Limited Ordinary Shares

Excluida de cotización

QTNT dejó de cotizar en bolsa el 30 de diciembre de 2022.

 

Acerca de: Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.

Empleados: 450

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre QTNT.

Gráficos de precios implementados con Lightweight Charts™